Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

被引:267
作者
Ohata, K
Hamasaki, K
Toriyama, K
Matsumoto, K
Saeki, A
Yanagi, K
Abiru, S
Nakagawa, Y
Shigeno, M
Miyazoe, S
Ichikawa, T
Ishikawa, H
Nakao, K
Eguchi, K
机构
[1] Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Dept Pathol, Inst Trop Med, Nagasaki 8528501, Japan
[3] Nagasaki Univ, Hlth Res Ctr, Nagasaki 852, Japan
关键词
core protein; hepatic steatosis; hepatitis C virus; hepatocellular carcinoma;
D O I
10.1002/cncr.11427
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of this study was to determine the relation between hepatic steatosis and hepatocarcinogenesis in patients with chronic HCV infection. METHODS. The authors studied 161 patients with chronic HCV infection who were diagnosed at Nagasaki University Hospital, Nagasaki, Japan, between January 1980 and December 1999. Age, gender, body mass index (BMI), habitual drinking, diabetes mellitus, serum alanine aminotransferase (ALT) level, HCV serotype, serum level of HCV core protein, interferon (IFN) treatment, hepatic fibrosis inflammation, and hepatic steatosis were studied with regard to their significance in the development of HCC using univariate and multivariate analyses. RESULTS. The cumulative incidence rates of HCC were 24%, 51%, and 63% at 5 years, 10 years, and 15 years, respectively. Multivariate analysis identified hepatic steatosis, together with aging, cirrhosis, and no IFN treatment, as independent and significant risk factors for HCC (P 0.0135, P = 0.0390, P = 0.0068, and P 0.0142, respectively). In addition, hepatic steatosis was correlated with BMI, serum ALT levels, and triglyceride levels. CONCLUSIONS. The findings of the current study indicate that hepatic steatosis is a risk factor for HCC in patients with chronic HCV infection. Patients with chronic HCV and hepatic steatosis should be monitored carefully for HCC. (C) 2003 American Cancer Society.
引用
收藏
页码:3036 / 3043
页数:8
相关论文
共 47 条
[1]   Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].
Adinolfi, LE ;
Gambardella, M ;
Andreana, A ;
Tripodi, MF ;
Utili, R ;
Ruggiero, G .
HEPATOLOGY, 2001, 33 (06) :1358-1364
[2]   THE HISTOLOGICAL FEATURES OF CHRONIC HEPATITIS-C AND AUTOIMMUNE CHRONIC HEPATITIS - A COMPARATIVE-ANALYSIS [J].
BACH, N ;
THUNG, SN ;
SCHAFFNER, F .
HEPATOLOGY, 1992, 15 (04) :572-577
[3]   Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets [J].
Barba, G ;
Harper, F ;
Harada, T ;
Kohara, M ;
Goulinet, S ;
Matsuura, Y ;
Eder, G ;
Schaff, Z ;
Chapman, MJ ;
Miyamura, T ;
Brechot, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1200-1205
[4]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[5]  
Brunetto MR, 1998, LANCET, V351, P1535
[6]   Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study [J].
Bruno, S ;
Silini, E ;
Crosignani, A ;
Borzio, F ;
Leandro, G ;
Bono, F ;
Asti, M ;
Rossi, S ;
Larghi, A ;
Cerino, A ;
Podda, M ;
Mondelli, MU .
HEPATOLOGY, 1997, 25 (03) :754-758
[7]   Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis [J].
Chiba, T ;
Matsuzaki, Y ;
Abei, M ;
Shoda, J ;
Aikawa, T ;
Tanaka, N ;
Osuga, T .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) :552-558
[8]   Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis [J].
Costet, P ;
Legendre, C ;
Moré, J ;
Edgar, A ;
Galtier, P ;
Pineau, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29577-29585
[9]   SENSITIVITY, SPECIFICITY, AND PREDICTABILITY OF BIOPSY INTERPRETATIONS IN CHRONIC HEPATITIS [J].
CZAJA, AJ ;
CARPENTER, HA .
GASTROENTEROLOGY, 1993, 105 (06) :1824-1832
[10]   Histopathology of chronic hepatitis C in relation to epidemiological factors [J].
Delladetsima, JK ;
Rassidakis, G ;
Tassopoulos, NC ;
Papatheodoridis, GV ;
Smyrnoff, T ;
Vafiadis, I .
JOURNAL OF HEPATOLOGY, 1996, 24 (01) :27-32